Alnylam plans to appeal Covid-19 vaccine patent ruling in case against Moderna
Alnylam agreed to a final judgment that Moderna did not infringe on two of Alnylam’s patents, though the company said Friday it plans to appeal the ruling.
Judge Colm Connolly of the US District Court for the District of Delaware issued an order last week against Alnylam on certain patent claims. The company sued Moderna in 2022, alleging in two suits that the company’s Covid-19 vaccine infringed on Alnylam patents. It also sued Pfizer, making similar allegations.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.